C7ORF11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.316400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.386200E-01
Normal-vs-Stage2
7.676600E-01
Normal-vs-Stage3
1.348030E-01
Normal-vs-Stage4
7.720000E-02
Stage1-vs-Stage2
4.577000E-01
Stage1-vs-Stage3
4.873900E-02
Stage1-vs-Stage4
3.053800E-01
Stage2-vs-Stage3
3.776000E-02
Stage2-vs-Stage4
5.933900E-02
Stage3-vs-Stage4
1.346450E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.236400E-01
Normal-vs-AfricanAmerican
7.610200E-01
Normal-vs-Asian
4.959800E-01
Caucasian-vs-AfricanAmerican
3.855200E-01
Caucasian-vs-Asian
3.718600E-01
AfricanAmerican-vs-Asian
2.581000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.068400E-01
Normal-vs-Female
7.542600E-01
Male-vs-Female
8.411800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.242200E-01
Normal-vs-Age(41-60Yrs)
4.398800E-01
Normal-vs-Age(61-80Yrs)
9.495200E-01
Normal-vs-Age(81-100Yrs)
2.270800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.113000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.779600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.392200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.236400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.128400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.169220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.226600E-01
Normal-vs-Daily Drinker
7.204400E-01
Normal-vs-Weekly Drinker
7.190200E-01
Normal-vs-Occasional Drinker
2.518600E-01
Normal-vs-Social Drinker
5.314600E-01
Non Drinker-vs-Daily Drinker
6.315000E-01
Non Drinker-vs-Weekly Drinker
6.877800E-01
Non Drinker-vs-Occasional Drinker
1.260420E-01
Non Drinker-vs-Social Drinker
3.247400E-01
Daily Drinker-vs-Weekly Drinker
9.716600E-01
Daily Drinker-vs-Occasional Drinker
4.349800E-01
Daily Drinker-vs-Social Drinker
6.776600E-01
Weekly Drinker-vs-Occasional Drinker
4.338600E-01
Weekly Drinker-vs-Social Drinker
6.695600E-01
Occasional Drinker-vs-Social Drinker
8.072200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.366400E-01
Normal-vs-Grade 2
9.733800E-01
Normal-vs-Grade 3
9.240800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.051800E-01
Grade 1-vs-Grade 3
8.718800E-01
Grade 1-vs-Grade 4
9.366400E-01
Grade 2-vs-Grade 3
2.009200E-01
Grade 2-vs-Grade 4
9.733800E-01
Grade 3-vs-Grade 4
9.240800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.181000E-01
Normal-vs-NonDiabetic
5.623600E-01
Diabetic-vs-NonDiabetic
3.113900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.774000E-01
Normal-vs-NoPancreatitis
6.673200E-01
Pancreatitis-vs-NoPancreatitis
6.975800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.443600E-01
Normal-vs-N1
7.805400E-01
N0-vs-N1
7.273600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.013000E-01
Normal-vs-TP53-NonMutant
9.909600E-01
TP53-Mutant-vs-TP53-NonMutant
9.776400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
